Joey Trantham, MD
Clinical Cardiac Electrophysiology · Panama City, FLNPI 1497774087
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 63.2% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $16,563 and has fallen 98.2% since, to $294 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 256 payments — averaging $86.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$14K
- Medical Device Business Services, Inc.$2K
- Medtronic$2K
- Novartis$449
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$409
- Boston Scientific$384
- plus $3K from 27 others
Across 3 payments — averaging $6740.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$20K
What the payments were for
- Speaking & faculty fees$12,20055%
- Travel & lodging$4,09618%
- Food & beverage$5,86726%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 31 | $14,005 |
| Medical Device Business Services, Inc. | 19 | $2,331 |
| Medtronic(2 entities) | 22 | $1,937 |
| Novartis | 35 | $449 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $409 |
| Boston Scientific | 8 | $384 |
| Amgen | 18 | $322 |
| E.r. Squibb & Sons, L.L.C. | 17 | $290 |
| Merck | 20 | $268 |
| Sanofi-aventis U.S. LLC | 8 | $258 |
| Boehringer Ingelheim | 8 | $181 |
| Amarin Pharma, Inc. | 8 | $173 |
| Chiesi USA, Inc. | 6 | $150 |
| Recor Medical Inc | 1 | $136 |
| AstraZeneca | 8 | $117 |
| Abbott | 3 | $103 |
| Bayer | 5 | $103 |
| Biosense Webster, Inc. | 3 | $87 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Philips North America LLC | 2 | $64 |
| Opsens Inc. | 1 | $49 |
| Pfizer | 3 | $46 |
| Cardiovascular Systems Inc. | 3 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Shockwave Medical, Inc | 1 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $12 |
| Cvrx, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$13,478
- Carto 3 System$1,837
- EMBLEM$199
- Paradise Ultrasound Renal Denervation System$136
- AZURE XT DR MRI SURESCAN$126
- SYMPLICITY G3$118
- Micra$116
- Reveal LINQ$109
- MULTAQ$108
- CROME DR MRI SURESCAN$101
- Advisa$101
How this compares
$22,171 in reported general payments places this provider in the 45th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 92 | $114,552 |
| EliquisApixaban | 74 | $104,441 |
| XareltoRivaroxaban | 71 | $87,638 |
| VerquvoVericiguat | 11 | $11,206 |
| Carvedilol ErCarvedilol Phosphate | 12 | $3,559 |
| Carvedilol | 309 | $2,976 |
| Digoxin | 105 | $2,716 |
| Losartan Potassium | 57 | $1,017 |
| ClopidogrelClopidogrel Bisulfate | 50 | $910 |
| Enalapril Maleate | 31 | $757 |
| Amlodipine Besylate | 54 | $571 |
| Atorvastatin Calcium | 34 | $355 |
| Pravastatin Sodium | 26 | $334 |
| Metoprolol Succinate | 32 | $328 |
| Metoprolol Tartrate | 11 | $318 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $449 | $114,55292 claims |
| PfizerEliquis | $46 | $104,44174 claims |
| Johnson & JohnsonXarelto | $14,005 | $87,63871 claims |
| MerckVerquvo | $268 | $11,20611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Panama City
- Saeed KhajaPanama City$55K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.